Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical exporter from India, specializing in Rituximab Biosimilar 100mg Injection with reliable international supply and fast global shipping services.
We supply high-quality oncology and immunotherapy biosimilars to hospitals, distributors, and healthcare institutions across the world, ensuring compliance with international quality standards.
💉 Rituximab Biosimilar 100mg Injection – Overview
Rituximab Biosimilar Injection is a monoclonal antibody used in the treatment of various autoimmune diseases and certain types of cancers. It works by targeting CD20-positive B-cells in the immune system.
🧬 Uses of Rituximab Biosimilar 100mg Injection
Non-Hodgkin’s Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with polyangiitis
Autoimmune disorders (as prescribed by specialists)
💊 Dosage Information
Administered only under medical supervision
Dosage depends on body condition, disease type, and doctor’s recommendation
Given via intravenous (IV) infusion
Hospital or clinical setting required
⚠️ Side Effects
Fever, chills, or infection risk
Fatigue and weakness
Nausea or vomiting
Low blood cell count
Allergic infusion reactions
Headache or dizziness
🚫 Precautions
Not recommended for patients with active severe infections
Monitor blood count regularly
Use only under oncologist or specialist supervision
Avoid self-administration
Inform doctor about allergy history before treatment
🌍 Global Export Destinations
We ensure fast and reliable export supply to:
🇦🇪 UAE – Dubai, Abu Dhabi, Sharjah
🇺🇸 USA – New York City, Los Angeles, Washington DC
🇬🇧 UK – London, Manchester, Birmingham
🇿🇦 South Africa – Johannesburg, Cape Town, Durban
🇸🇬 Singapore
🇵🇭 Philippines
🇨🇦 Canada
🚀 Why Choose Cordium Pharmaceuticals Pvt Ltd?
WHO-GMP certified quality standards
Trusted Indian pharma exporter
Global logistics support
Competitive pricing for bulk supply
Fast international shipping network
High-demand biosimilar oncology products
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
We supply high-quality oncology and immunotherapy biosimilars to hospitals, distributors, and healthcare institutions across the world, ensuring compliance with international quality standards.
💉 Rituximab Biosimilar 100mg Injection – Overview
Rituximab Biosimilar Injection is a monoclonal antibody used in the treatment of various autoimmune diseases and certain types of cancers. It works by targeting CD20-positive B-cells in the immune system.
🧬 Uses of Rituximab Biosimilar 100mg Injection
Non-Hodgkin’s Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with polyangiitis
Autoimmune disorders (as prescribed by specialists)
💊 Dosage Information
Administered only under medical supervision
Dosage depends on body condition, disease type, and doctor’s recommendation
Given via intravenous (IV) infusion
Hospital or clinical setting required
⚠️ Side Effects
Fever, chills, or infection risk
Fatigue and weakness
Nausea or vomiting
Low blood cell count
Allergic infusion reactions
Headache or dizziness
🚫 Precautions
Not recommended for patients with active severe infections
Monitor blood count regularly
Use only under oncologist or specialist supervision
Avoid self-administration
Inform doctor about allergy history before treatment
🌍 Global Export Destinations
We ensure fast and reliable export supply to:
🇦🇪 UAE – Dubai, Abu Dhabi, Sharjah
🇺🇸 USA – New York City, Los Angeles, Washington DC
🇬🇧 UK – London, Manchester, Birmingham
🇿🇦 South Africa – Johannesburg, Cape Town, Durban
🇸🇬 Singapore
🇵🇭 Philippines
🇨🇦 Canada
🚀 Why Choose Cordium Pharmaceuticals Pvt Ltd?
WHO-GMP certified quality standards
Trusted Indian pharma exporter
Global logistics support
Competitive pricing for bulk supply
Fast international shipping network
High-demand biosimilar oncology products
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Keywords
